Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Epidemiological survey of tick-borne encephalitis virus and Anaplasma phagocytophilum co-infections in patients from regions of the Czech Republic endemic for tick-borne diseases

P Zeman, P Pazdiora, V Chmelik, J Januska, K Sedivy, AA Guglielmone, JA Iriarte, Z Medkova

. 2007 ; 119 (17) : 538-543.

Jazyk angličtina Země Rakousko

Perzistentní odkaz   https://www.medvik.cz/link/bmc10026639
E-zdroje Online

NLK Medline Complete (EBSCOhost) od 2003-01-01 do Před 1 rokem

During the period 2000-2003, patients hospitalized for suspected tick-borne encephalitis in the Czech Republic were screened for possible A. phagocytophilum co-infection. Blood samples taken at admission were tested for the presence of A. phagocytophilum DNA by nested PCR using a modified target sequence as an internal control, and sera were tested for the presence of antibodies by indirect immunofluorescence and western blotting methods using cell-culture-derived antigens. To verify the assay specificity, a set of 45 sera of Patagonian residents served as a non-tick-exposed control group, and a set of 14 B. henselae-positive sera was used to check cross-reactivity. Of 809 patients hospitalized, 80 (9.9%) showed IgG antibodies reactive to A. phagocytophilum at > or =80 (reciprocal dilution factor) and 50 (6.2%) at > or =160; two (0.2%) patients showed elevated IgM titers of 40. No full blood obtained from 162 patients tested positive in PCR when false negativity was excluded. During hospitalization, the diagnosis of tick-borne encephalitis was confirmed in 536 patients, 57 (10.6%) of whom had anti-A. phagocytophilum IgG antibodies reactive at > or =80 and 41 (7.6%) at > or =160, which did not differ significantly from the whole set (P = 0.66/0.30), the maximum IgG titer registered was 5120, and no IgM titer reached the 40 cut-off. Available paired sera from 189 tick-borne encephalitis patients showed no significant shifts, but one case of slight seroconversion (IgG shift from < 80 to 320) was detected in one of the non-tick-borne encephalitis patients. The sex of the patient showed no significance for the prevalence of A. phagocytophilum antibodies; however, the seropositive patients were older on average than those who were seronegative (43.5 +/- 15.9 vs. 37.9 +/- 18.3 years, P = 0.05). Clinical manifestation of the disease did not differ noticeably between patients with and without A. phagocytophilumreactive antibodies, except for fever duration, which was significantly longer in patients with titers > or =1280. Overall, A. phagocytophilum co-infection did not seem to be a frequent and/or significant complication of tick-borne encephalitis acquired in the Czech Republic.

000      
00000naa 2200000 a 4500
001      
bmc10026639
003      
CZ-PrNML
005      
20111210192419.0
008      
101019s2007 au e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a au
100    1_
$a Zeman, Petr $7 xx0101633
245    10
$a Epidemiological survey of tick-borne encephalitis virus and Anaplasma phagocytophilum co-infections in patients from regions of the Czech Republic endemic for tick-borne diseases / $c P Zeman, P Pazdiora, V Chmelik, J Januska, K Sedivy, AA Guglielmone, JA Iriarte, Z Medkova
314    __
$a Medical Laboratories, Konevova 205, Prague, Czech Republic. zeman3@post.cz
520    9_
$a During the period 2000-2003, patients hospitalized for suspected tick-borne encephalitis in the Czech Republic were screened for possible A. phagocytophilum co-infection. Blood samples taken at admission were tested for the presence of A. phagocytophilum DNA by nested PCR using a modified target sequence as an internal control, and sera were tested for the presence of antibodies by indirect immunofluorescence and western blotting methods using cell-culture-derived antigens. To verify the assay specificity, a set of 45 sera of Patagonian residents served as a non-tick-exposed control group, and a set of 14 B. henselae-positive sera was used to check cross-reactivity. Of 809 patients hospitalized, 80 (9.9%) showed IgG antibodies reactive to A. phagocytophilum at > or =80 (reciprocal dilution factor) and 50 (6.2%) at > or =160; two (0.2%) patients showed elevated IgM titers of 40. No full blood obtained from 162 patients tested positive in PCR when false negativity was excluded. During hospitalization, the diagnosis of tick-borne encephalitis was confirmed in 536 patients, 57 (10.6%) of whom had anti-A. phagocytophilum IgG antibodies reactive at > or =80 and 41 (7.6%) at > or =160, which did not differ significantly from the whole set (P = 0.66/0.30), the maximum IgG titer registered was 5120, and no IgM titer reached the 40 cut-off. Available paired sera from 189 tick-borne encephalitis patients showed no significant shifts, but one case of slight seroconversion (IgG shift from < 80 to 320) was detected in one of the non-tick-borne encephalitis patients. The sex of the patient showed no significance for the prevalence of A. phagocytophilum antibodies; however, the seropositive patients were older on average than those who were seronegative (43.5 +/- 15.9 vs. 37.9 +/- 18.3 years, P = 0.05). Clinical manifestation of the disease did not differ noticeably between patients with and without A. phagocytophilumreactive antibodies, except for fever duration, which was significantly longer in patients with titers > or =1280. Overall, A. phagocytophilum co-infection did not seem to be a frequent and/or significant complication of tick-borne encephalitis acquired in the Czech Republic.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a věkové faktory $7 D000367
650    _2
$a senioři $7 D000368
650    _2
$a Anaplasma phagocytophilum $x genetika $7 D041081
650    _2
$a protilátky bakteriální $x imunologie $x krev $7 D000907
650    _2
$a western blotting $7 D015153
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a zkřížené reakce $7 D003429
650    _2
$a DNA bakterií $x analýza $7 D004269
650    _2
$a ehrlichióza $7 D016873
650    _2
$a klíšťová encefalitida $7 D004675
650    _2
$a fluorescenční protilátková technika nepřímá $7 D019084
650    _2
$a lidé $7 D006801
650    _2
$a imunoglobulin G $x imunologie $x krev $7 D007074
650    _2
$a lidé středního věku $7 D008875
650    _2
$a polymerázová řetězová reakce $7 D016133
651    _2
$a Česká republika $x epidemiologie $7 D018153
700    1_
$a Pazdiora, Petr, $d 1956- $7 nlk19990073671
700    1_
$a Chmelík, Václav $7 xx0106703
700    1_
$a Januška, Jiří $7 xx0073929
700    1_
$a Šedivý, Karel. $7 xx0216003
700    1_
$a Guglielmone, Alberto A.
700    1_
$a Iriarte, Jorge A.
700    1_
$a Medková, Zuzana, $d 1962- $7 xx0065659
773    0_
$w MED00010762 $t Wiener klinische Wochenschrift $g Roč. 119, č. 17 (2007), s. 538-543 $x 0043-5325
910    __
$a ABA008 $b x $y 7
990    __
$a 20110112165539 $b ABA008
991    __
$a 20110204114948 $b ABA008
999    __
$a ok $b bmc $g 801746 $s 666499
BAS    __
$a 3
BMC    __
$a 2007 $b 119 $c 17 $d 538-543 $i 0043-5325 $m Wiener klinische Wochenschrift $n Wien Klin Wochenschr $x MED00010762
LZP    __
$a 2010-B/mk

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...